Search

Home > OncLive® On Air > 48: FDA Approval Insights: Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Podcast: OncLive® On Air
Episode:

48: FDA Approval Insights: Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Category: Science & Medicine
Duration: 00:13:13
Publish Date: 2020-04-27 10:50:28
Description: In our exclusive interview, Aditya Bardia, MD, of Massachusetts General Hospital Cancer Center, discusses the FDA approval of sacituzumab govitecan in metastatic triple-negative breast cancer, the implications of the approval, and ongoing research with the agent.
Total Play: 0

Some more Podcasts by Audioboom

70+ Episodes
Faith Moveme ..    
100+ Episodes
Videnskab.dk .. 5     1
20+ Episodes
Vidensselska ..    
10+ Episodes
Odd Jobs    
20+ Episodes
Aaron and Ga ..    
100+ Episodes
Ladies of Li .. 4     3
100+ Episodes
Chamber Podc ..    
10+ Episodes
IT'S A GROWN ..